TMARC Pilot Studies - Completed

Self-Generation of Prospective Memory in HIV-Infected METH Users (Weber)

Agency: TMARC
PI: Weber, Erica, M.S.


Methamphetamine (MA) dependence frequently co-occurs with HIV infection and greatly increases the likelihood of poorer disease outcomes, in part due to high rates of antiretroviral (ARV) nonadherence, for which there are presently no reliably effective clinical interventions in HIV-infected MA users. Neurocognitive impairment is an important risk factor for non-adherence and is therefore a viable candidate for interventions that might improve health outcomes. One relevant aspect of cognition may be a prime target for intervention is prospective memory (PM), which is the ability to remember to perform an intended action at a specific point in the future (i.e., “remembering to remember”).  HIV-associated deficits in PM are strongly and uniquely associated with declines in everyday functioning that greatly burden our healthcare systems, particularly ARV nonadherence, because individuals must remember to take their medications as prescribed. However, there are presently no empirically validated, theory-driven techniques to improve adherence-related cognitive functions such as PM in MA and HIV. One novel and potentially powerful approach to improving PM is self-generation, a process by which one must produce the material to be remembered. Considered within the framework of Einstein and McDaniel’s Multi-Process Theory of PM, self-generation may bolster PM performance by enhancing the automatic nature of encoding, thereby decreasing demands on dysfunctional strategic (i.e., executive) aspects of encoding and cue monitoring that underlie PM impairment in MA/HIV individuals. Self-generation may therefore be a highly effective means of enhancing PM in this high-risk population. The proposed project seeks to: 1) evaluate the efficacy of self-generation on PM performance in MA/HIV adults on basic experimental, clinical laboratory, and naturalistic PM paradigms; 2) determine the neurocognitive moderators of self-generation on PM in MA/HIV; and 3) explore potential demographic, psychiatric, disease, and addiction correlates of the self-generation effect on PM in MA/HIV.  These aims will be evaluated in 55 well-characterized HIV+ MA users and 25 seronegative comparison subjects drawn from the HNRP (including TMARC), who will complete a series of self-generation PM experiments in the laboratory and in a naturalistic setting. Results from this study are intended to directly inform the development of PM-based strategies to improve adherence in MA/HIV.

Sponsored by NIH/NIDA P50DA026306

Copyright ©2009 TRANSLATIONAL METHAMPHETAMINE AIDS RESEARCH CENTER | University of California, San Diego | HNRP | For questions regarding this site, please contact the webmaster